Addressing parents' concerns: Do vaccines cause allergic or autoimmune diseases?

Pediatrics

Volumn 111, Issue 3, 2003, Pages 653-659

  Offit, Paul A ^a,c   Hackett, Charles J ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Allergies; Asthma; Chronic arthritis; Diabetes; Multiple sclerosis; Vaccine safety; Vaccines

Indexed keywords

IMMUNOGLOBULIN E; VACCINE;

ALLERGY; ASTHMA; AUTOIMMUNE DISEASE; BACTERIUM; CHRONIC ARTHRITIS; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFECTION; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VIRUS;

ARTHRITIS; ATTITUDE TO HEALTH; AUTOIMMUNE DISEASES; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 1; HUMANS; HYPERSENSITIVITY; MULTIPLE SCLEROSIS; PARENTS; VACCINES;

EID: 0037342487     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.111.3.653     Document Type: Review

References (92)

1. Kemp T, Pearce N, Fitzharris P, et al. Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology, 1997;8:678-680
2. Odent MR, Culpin EE, Kimmel T. Pertussis vaccination and asthma: is there a link? JAMA. 1994;272:592-593
3. Hurwitz EL, Morgenstrn H. Effects of diphtheria-tetanus-pertussis or tetanus vaccination on allergies and allergy-related respiratory symptoms among children and adolescents in the United States. J Manipulative Physiol Ther. 2000;23:81-90
4. Downes KA, Domen RE, McCarron KF, et al. Acute autoimmune hemolytic anemia following DTP vaccination: fatal case and review of the literature. Clin Pediatr. 2001;40:355-358
5. Ronchi F, Cecchi P, Falcioni F, et al. Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine. Arch Dis Child. 1998;78:273-274
6. Neau D, Bonnet R, Michaud M, et al. Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven cases. Scand J Infect Dis. 1998;30:115-118
7. Perez C, Loza E, Tinture T. Giant cell arteritis after influenza vaccination. Arch Intern Med. 2000;160:2677
8. Pope JE, Stevens A, Howson W, Bell DA. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol. 1998;25:1687-1693
9. Maillefert JF, Sibilia J, Toussirot E, et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology. 1999;38:978-983
10. Robles DT, Eisenbarth GS. Type 1A diabetes induced by infection and immunization. J Autoimmunity. 2001;16:355-362
11. Classen JB, Classen DC. Vaccines modulate IDDM. Diabetologia. 1996;39:500-502
12. Classen JB. Childhood immunisation and diabetes mellitus. N Z Med J. 1996;109:195
13. Arya SC. Acute disseminated encephalomyelitis associated with poliomyelitis vaccine. Pediatr Neural. 2001;24:325
14. Konstantinou D, Paschalis C, Maraziotis T, et al. Two episodes of leukeencephalitis associated with recombinant hepatitis B vaccination in a single patient. Clin Infect Dis. 2001;33:1772-1773
15. Cohen AD, Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmunity. 1996;9:699-703
16. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity "vaccinosis": a dangerous liaison? J Autoimmunity 2000;14:1-10
17. Rose NR. Immunologic hazards associated with vaccination of humans. J Autoimmunity. 2000;14:11-13
18. Nossal GJV. Vaccination and autoimmunity. J Autoimmunity. 2000;14:13-15
19. Institute of Medicine. Immunization Safety Review: Multiple Immunizations and Immune Dysfunction. Washington, DC: Institute of Medicine; 2002
20. Kay AB. Allergy and allergic diseases. N Engl J Med. 2001;344:30-37
21. Prescott SL, Macaubas C, Holt BJ, et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol. 1998;160:4730-4737
22. Ball TM, Castro-Rodriguez JA, Griffith KA, et al. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med. 2000;343:538-543
23. Christiansen SC. Day care, siblings, and asthma - please, sneeze on my child. N Engl J Med 2000;343:574-575
24. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol. 2001;1:69-75
25. Cookson W, Moffatt M. Asthma: an epidemic in the absence of infection? Science. 1997;275:41-42
26. Yazdanbakhsh M, Kremsner PG, van Rec R. Allergy, parasites, and the hygiene hypothesis. Science. 2002;296:490-494
27. Ponsonby A-L, Douper D, Dwyer T, et al. Relationship between early lite respiratory illness, family size over time, and the development of asthma and hay fever: a seven-year follow-up study. Thorax. 1999;54:664-669
28. Illi S, von Mutius E, Lau S, et al. Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. Br Med J. 2001;322:390-395
29. Dingle I, Badger GF, Jordan WS Jr. Illness in the Home: A Study of 25,000 Illnesses in a Group of Cleveland Families. Cleveland, OH: The Press of Western Reserve University; 1964
30. van den Biggelaar AH, van Ree R, Rodrigues LV, et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasiteinduced interleukin-10. Lancet 2000;356:1723-1727
31. DuBois RM. Interferon gamma-1b for the treatment of idiopathic pulmonary fibrosis. N Engl J Med. 1999;341:1302-1304
32. DeStefano F, Gu D, Kramarz P, et al. Childhood vaccinations and the risk of asthma. Pediatr Infect Dis J. 2002;21:498-504
33. Nilsson L, Kjellman N, Bjorksten B. A randomized controlled trial of the effect of pertussis vaccines on atopic disease. Arch Pediatr Adolesc Med. 1998;152:734-738
34. Kramarz P, DeStefano F, Gargiullo PM, et al. Does influenza vaccination exacerbate asthma? Arch Fam Med. 2000;9:617-623
35. Wickens K, Crane J, Kemp T, et al. A case-control study of risk factors for asthma in New Zealand children. Aust N Z Public Health. 2001;25:44-49
36. Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH, et al. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet. 1998;351:326-331
37. Reid DW, Bromly CL, Stenton SC, et al. A double-blind placebo-controlled study of the effect of influenza vaccination on airway responsiveness in asthma. Respir Med. 1998;92:1010-1011
38. Gruber C, Kulig M, Bergmann R, Guggenmoos-Holzmann I, Wahn U, MAS-90 Study Group. Delayed hypersensitivity to tuberculin, total immunoglobulin E, specific sensitization, and atopic manifestations in longitudinally followed early Bacille Calmett-Guerin-vaccinated and nonvaccinated children. Pediatrics. 2001;107(3). Available at: http://www.pediatrics.org/cgi/content/full/107/3/e36
39. Anderson HR, Poloniecki JD, Strachan DP, et al. Immunization and symptoms of atopic disease in children: results from the international study of asthma and allergies in children. Am J Public Health. 2001;91:1126-1129
40. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345:340-350
41. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nat Med. 2001;7:899-905
42. Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 1977;20:7-17
43. Zabriskie JB, Freimer EH. An immunological relationship between the Group A streptococcus and mammalian muscle. J Exp Med. 1966;124:661-678
44. Steinman L. Multiple sclerosis: a two-stage disease. Nat Immunol. 2001;2:762-764
45. Regner M, Lambert P-H. Autoimmunity through infection or immunization? Nat Immunol. 2001;2:185-188
46. Albert LJ, Inman RD. Molecular mimicry and autoimmunity. N Engl J Med. 1999;341:2068-2074
47. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000;342:938-952
48. Chou YK, Bourdette DN, Offner H, et al. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J Neuroimmunol. 1992;38:105-113
49. Fujinami RS, Oldstone MA. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 1985;230:1043-1045
50. Herroelen L, de Keyser J, Ebinger G. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet. 1991;338:1174-1175
51. Nadler JP. Multiple sclerosis and hepatitis B vaccination. Clin Infect Dis. 1993;17:928-929
52. Fourrier A, Touze E, Alperovitch A, Begaud B. Association between hepatitis B vaccine and multiple sclerosis: a case-control study. Pharmacoepidemiol Drug Saf. 1999;8(suppl):S140-S141
53. Sturkenboom MCJM, Abenhaim L, Wolfson C, et al. Vaccinations, demyelination, and multiple sclerosis study (VDAMS): a populationbased study in the UK. Pharmacoepidemiol Drug Saf. 1999;8(suppl): S170-S171
54. Touze E, Gout O, Verdier-Taillefer MH, et al. The first episode of central nervous system demyelinization and hepatitis B vaccination. Rev Neurol. 2000;156:242-246
55. Wucherpfennig KW, Stominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 1995;80:695-705
56. Robinson, WS. Hepatitis B virus and hepatitis D virus. In Mandell, GL, Bennett JE, Dolin R, eds. Principles and Practices of Infectious Diseases. 5th ed. Philadelphia, PA: Churchill Livingstone; 2000:1656
57. De Keyser J, Zwanikken C, Boon M. Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis. J Neurol Sci. 1998;159:51-53
58. Hall A, Kane M, Roure C, Meheus A. Multiple sclerosis and hepatitis B vaccine? Vaccine. 1999;17:2473-2475
59. Ascherio A, Zhang SM, Hernan MA, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001;344:327-332
60. Confavreux C, Suissa S, Saddier P, et al. Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med. 2001;344:319-326
61. Moriabadi NF, Niewiesk S, Kruse N, et al. Influenza vaccination in MS: absence of T-cell response against white matter proteins. Neurology. 2001;56:938-943
62. Miller AE, Morgante LA, Buchwald LY, et al. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology. 1997;48:312-314
63. Notkins AL, Lernmark A. Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest. 2001;108:1247-1252
64. Bottazzo GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974;2:1279-1283
65. Baekkeskov S. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature. 1982;298:167-169
66. Baekkeskov S. Identification of the 64K autoantigen in insulindependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 1990;347:151-156
67. Lan MS, Wasserfall C, Maclaren NK, Notkins AL. 1A-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1996;93:6367-6370
68. Palmer JP. Insulin autoantbodies: their role in the pathogenesis of IDDM. Diabetes Metab Rev. 1987;3:1005-1015
69. Bingley PJ. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes. 1997;46:1701-1710
70. McEvoy RC, Fedun B, Cooper LZ, et al. Children at high risk of diabetes mellitus: New York studies of families with diabetes and children with congenital rubella syndrome. Adv Exp Med Biol. 1988;246:221-227
71. Lindberg B, Ahlfors K, Carlsson A, et al. Previous exposure to measles, mumps, and rubella - but not vaccination during adolescence correlates to the prevalence of pancreatic and thyroid autoantibodies. Pediatrics. 1999;104(1). Available at: http://www.pediatrics.org/cgi/content/full/104/1/e12
72. Rewers M, Atkinson M. The possible role of enteroviruses in diabetes mellitus. In: Rotbart HA, ed. Human Entervirus Infections. Washington, DC: American Society for Microbiology; 1995:353-385
73. Yoon JW, Austin M, Onodera T, Notkins AL. Isolation of virus from the pancreas of a child with diabetic ketoacidosis (virus-induced diabetes mellitus). N Engl J Med. 1979;300:1173-1179
74. Jaeckel E, Manns M, von Herrath M. Viruses and diabetes. Ann N Y Acad Sci. 2002;958:7-25
75. Classen DC, Classen JB. The timing of pediatric immunization and the risk of insulin-dependent diabetes mellitus. Infect Dis Clin Pract. 1997;6:449-454
76. Dahlquist G, Gothefors L. The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. Diabetologia. 1995;38:873-874
77. Allen HF, Klingensmith GJ, Jensen P, et al. Effect of bacillus Calmette-Guérin vaccination of new-onset type 1 diabetes. Diabetes Care, 1999;22:1703-1707
78. Institute for Vaccine Safety Diabetes Workshop Panel. Childhood immunizations and type 1 diabetes: summary of an Institute for Vaccine Safety Workshop. Pediatr Infect Dis J. 1999;18:217-222
79. Black SB, Lewis E, Shinefield H, et al. Lack of association between receipt of conjugate Haemophilus influenzae type b vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohort. Pediatr Infect Dis J. 2002;21:568-569
80. DeStefano F, Mullooly JP, Okoro CA, et al. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics 2001;108(6). Available at: http://www.pediatrics.org/cgi/content/full/108/6/e112
81. Heijbel H, Chen RT, Dahlquist G. Cumulative incidence of childhood-onset IDDM is unaffected by pertussis immunization. Diabetes Care. 1997;20:173-175
82. Graves PM, Barriga KJ, Norris JM, et al. Lack of association between early childhood immunizations and β-cell autoimmunity. Diabetes Care. 1999;22:1694-1697
83. Hummel M, Fuchtenbusch M, Schenker M, et al. No major association between breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYD1AB study. Diabetes Care, 2000;23:969-974
84. Steere AC, Gross D, Meyer AL, Huber BT. Autoimmune mechanisms in antibiotic treatment-resistant Lyme arthritis. J Autoimmunity. 2001;16:263-268
85. Chen J, Field JA, Glickstein L, et al. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer-surface protein A (OspA) of Borrelia burgdorferi. Arthritis Rheum. 1999;42:1813-1822
86. Steere AC, Dwyer E, Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med. 1990;323:219-223
87. Carlson D, Hernandez J, Bloom BJ, et al. Lack of Borrelia burgdorferi DNA in synovial samples in patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 1999;42:2705-2709
88. Gross DM, Forsthuber T, Tary-Lehmann M, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science. 1998;281:703-706
89. Centers for Disease Control and Prevention. Recommendations for the use of Lyme disease vaccine. MMWR Morb Mortal Wkly Rep. 1999;48: RR-7
90. Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med. 1998;339:209-215
91. Sigal LH, Zahradnik JM, Lavin P, et al. A vaccine consisting of recombinant Borrelia burgdorferi outer surface protein A to prevent Lyme disease. N Engl J Med. 1998;339:216-222
92. Lathrop SL, Ball R, Haber P, et al. Adverse event reports following vaccination for Lyme disease: December 1998-July 2000. Vaccine. 2002;20:1603-1608